Search research articles
Contact Us
Filters
Showing results (21-30 of 51) with videos related to
Page
of 6
Sort By:
Rheumatology (Oxford, England)
|
March 18, 2022
Impact of remission and low disease activity on health-related quality of life in patients with systemic lupus erythematosus
Sharzad Emamikia, Shereen Oon, Alvaro Gomez, et al.
JCI Insight
|
October 5, 2016
A cytotoxic anti-IL-3Rα antibody targets key cells and cytokines implicated in systemic lupus erythematosus
Shereen Oon, Huy Huynh, Tsin Yee Tai, et al.
Iscience
|
July 17, 2023
CSL362 potently and specifically depletes pDCs <i>in</i><i>vitro</i> and ablates SLE-immune complex-induced IFN responses
Katherine A Monaghan, Alberta Hoi, Cristina Gamell, et al.
The Lancet. Rheumatology
|
August 29, 2024
Attainment of remission and low disease activity after treatment with belimumab in patients with systemic lupus erythematosus: a post-hoc analysis of pooled data from five randomised clinical trials
Ioannis Parodis, Julius Lindblom, Roger A Levy, et al.
Seminars in Arthritis and Rheumatism
|
February 21, 2017
Does expert opinion match the operational definition of the Lupus Low Disease Activity State (LLDAS)? A case-based construct validity study
Vera Golder, Molla Huq, Kate Franklyn, et al.
Arthritis Research & Therapy
|
May 12, 2026
Clinical characteristics and response to standard-of-care treatment in systemic lupus erythematosus patients with or without anti-ribonucleoprotein (RNP) antibodies: an Australian, multi-centre cohort study
Rangi Kandane-Rathnayake, Rachel Koelmeyer, Shereen Oon, et al.
Arthritis Care & Research
|
October 18, 2024
Impact of Season, Environmental Temperature, and Humidity on Raynaud Phenomenon in an Australian Systemic Sclerosis Cohort
Laura Taylor, Dylan Hansen, Kathleen Morrisroe, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
November 25, 2014
Bcl-2 antagonists kill plasmacytoid dendritic cells from lupus-prone mice and dampen interferon-α production
Yifan Zhan, Emma M Carrington, Hyun-Ja Ko, et al.
RMD Open
|
July 15, 2026
Multicentre international audit of IMACS malignancy screening guidelines in idiopathic inflammatory myopathies: insights from the myositis audit and research collaborative group
Jessica Day, Lekshmi Minikumari Rahulan, Samuel Katsuyuki Shinjo, et al.
Lupus Science & Medicine
|
January 20, 2025
Longitudinal associations of flare and damage accrual in patients with systemic lupus erythematosus
Rangi Kandane-Rathnayake, Dominique Milea, Worawit Louthrenoo, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 51) with videos related to
Sort By:
Page
of 6
Rheumatology (Oxford, England)
|
March 18, 2022
Impact of remission and low disease activity on health-related quality of life in patients with systemic lupus erythematosus
Sharzad Emamikia, Shereen Oon, Alvaro Gomez, et al.
JCI Insight
|
October 5, 2016
A cytotoxic anti-IL-3Rα antibody targets key cells and cytokines implicated in systemic lupus erythematosus
Shereen Oon, Huy Huynh, Tsin Yee Tai, et al.
Iscience
|
July 17, 2023
CSL362 potently and specifically depletes pDCs <i>in</i><i>vitro</i> and ablates SLE-immune complex-induced IFN responses
Katherine A Monaghan, Alberta Hoi, Cristina Gamell, et al.
The Lancet. Rheumatology
|
August 29, 2024
Attainment of remission and low disease activity after treatment with belimumab in patients with systemic lupus erythematosus: a post-hoc analysis of pooled data from five randomised clinical trials
Ioannis Parodis, Julius Lindblom, Roger A Levy, et al.
Seminars in Arthritis and Rheumatism
|
February 21, 2017
Does expert opinion match the operational definition of the Lupus Low Disease Activity State (LLDAS)? A case-based construct validity study
Vera Golder, Molla Huq, Kate Franklyn, et al.
Arthritis Research & Therapy
|
May 12, 2026
Clinical characteristics and response to standard-of-care treatment in systemic lupus erythematosus patients with or without anti-ribonucleoprotein (RNP) antibodies: an Australian, multi-centre cohort study
Rangi Kandane-Rathnayake, Rachel Koelmeyer, Shereen Oon, et al.
Arthritis Care & Research
|
October 18, 2024
Impact of Season, Environmental Temperature, and Humidity on Raynaud Phenomenon in an Australian Systemic Sclerosis Cohort
Laura Taylor, Dylan Hansen, Kathleen Morrisroe, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
November 25, 2014
Bcl-2 antagonists kill plasmacytoid dendritic cells from lupus-prone mice and dampen interferon-α production
Yifan Zhan, Emma M Carrington, Hyun-Ja Ko, et al.
RMD Open
|
July 15, 2026
Multicentre international audit of IMACS malignancy screening guidelines in idiopathic inflammatory myopathies: insights from the myositis audit and research collaborative group
Jessica Day, Lekshmi Minikumari Rahulan, Samuel Katsuyuki Shinjo, et al.
Lupus Science & Medicine
|
January 20, 2025
Longitudinal associations of flare and damage accrual in patients with systemic lupus erythematosus
Rangi Kandane-Rathnayake, Dominique Milea, Worawit Louthrenoo, et al.
Page
of 6